NEW YORK, NY / ACCESSWIRE / November 25, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a 3Q14 update on Youngevity International, Inc. (OTCQX: YGYI), a fast-growing, innovative, multi-dimensional company that is a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channels.
The update note is available here: YGYI 3Q14 Update. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's. The report will also be available on these platforms.
Ajay Tandon, CEO of SeeThruEquity commented, "The company reported that 50% of the revenue growth came from organic sales growth in the Direct Sales segment, 25% came from acquisitions and the final 25% came from the Green Coffee Distribution, a new business within the Commercial Coffee division. Youngevity has done an excellent job of deriving organic growth from its acquired companies, and highlighted a few examples of this on its 3Q14 conference call. We are maintaining our 12-month target price of $0.49."
Additional highlights are as follows:
Youngevity reports record revenues
Youngevity reported record net revenues in 3Q14 of $37.6mn, up 77.3% compared to 3Q13. Growth was strong during the quarter for both of Youngevity's operating segments, Direct Sales and Commercial Coffee. The company reported that 50% of the revenue growth came from organic sales growth in the Direct Sales segment, 25% came from acquisitions and the final 25% came from the Green Coffee Distribution, a new business within the Commercial Coffee division. Youngevity plans to continue to grow the company through increased product offerings, an expanded geographic footprint and through acquisitions. On its 3Q14 conference call, Youngevity management described specific examples of robust organic growth coming from acquired companies once their products had been presented to the company's large network of direct sellers. Biometics International, acquired in November 2013, is a health company and an innovator in advanced liquid nutritional supplements. When it was acquired, Biometics was contributing approximately $100k per month to Youngevity's total revenue. In 3Q14, Youngevity reported that Biometics contributed revenues in excess of $1mn.
Private placement shores up balance sheet
On September 15, 2014, Youngevity announced the completion of a $4.75mn private placement. TriPoint Global Equities, LLC acted as sole placement agent in the transaction, which consisted of secured convertible notes and warrants. Youngevity reported $5.4mn in cash and equivalents on its balance sheet as of September 30, 2014.
Please review important disclosures on our website at www.seethruequity.com.
About Youngevity International, Inc.
Youngevity International Inc., (YGYI) (www.YGYI.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a "network of networks". The Company also is a vertically-integrated producer of the finest coffees for the commercial, retail and direct sales channels. The Company was formed after the merger of Youngevity Essential Life Sciences (www.youngevity.com) and Javalution Coffee Company in the summer of 2011. Formerly known as AL International, Inc., the Company changed its name to Youngevity International, Inc. in July 2013.
About SeeThruEquity
SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. We do not conduct any investment banking or commission based business. We are approved to contribute our research to Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks and distribute our research to our database of opt-in investors. We also contribute our estimates to Thomson Estimates, the leading estimates platform on Wall Street.
For more information visit www.seethruequity.com.
Contact:
Ajay Tandon
SeeThruEquity
(646) 495-0939
SOURCE: SeeThruEquity